Patent Royalty Term means, on a country-by-country and product-by-product basis with respect to a particular NIPT IVD Product in the NIPT IVD Field, the time period beginning on the Effective Date and ending upon the date of expiration of the last to Expire Pooled Patent having at least one Valid Issued Claim covering the applicable NIPT IVD Product or its use in the NIPT IVD Field.
Patent Royalty Term. Section 6.2(a)
Patent Royalty Term. Section 6.2(a) “Patent Term Extensions” —Section 9.7 “Product Collaboration Inventions”—Section 9.1(b)
Examples of Patent Royalty Term in a sentence
In the event that Dermira undergoes a Liquidity Event during the Rose U Patent Royalty Term, it shall pay Licensor a royalty of $[*].
Quarter in the Royalty Term and the BMS Patent Royalty Term, as applicable.
This Agreement shall commence as of the Effective Date and, unless sooner terminated in accordance with the terms hereof or by mutual written consent, shall expire in each country in the Territory, on a country-by-country basis, upon the expiration of both the Royalty Term and BMS Patent Royalty Term in such country.
If the Patent Royalty Term is in effect in a Jurisdiction, Zogenix shall owe Durect “Patent Royalties” with respect to annual Net Sales in such Jurisdiction.
In a Jurisdiction where the Patent Royalty Term is in effect, Alpharma shall owe Durect Patent Royalties with respect to calendar year Net Sales of Product in such Jurisdiction.
More Definitions of Patent Royalty Term
Patent Royalty Term shall have the meaning given in Section 5.3(a).
Patent Royalty Term means, with respect to each Product in each country, the term, if any, during which (a) a Valid Claim remains in effect and would be infringed but for the license granted by this Agreement, by the use, offer for sale, sale or import of such Product in such country in the Field and (b) no Third Party generic product that has received marketing approval pursuant to an abbreviated regulatory process under which the applicable Third Party or Competent Authority has relied on data or other information in any Registration for the applicable Product is commercially available in such country.
Patent Royalty Term means, on a country-by country basis, and on a CAR T Product by CAR T Product and Companion Diagnostic by Companion Diagnostic basis, the period beginning upon the date of First Commercial Sale of a CAR T Product or Companion Diagnostic (if appropriate) respectively in the applicable country and ending upon the last to occur of: (a) expiration of the last Valid Patent Claim covering the CAR T Product or Companion Diagnostic or its manufacture, use or sale in the applicable country; or (b) except to the extent unenforceable on a country-by-country basis, expiration of exclusivity based on regulatory protection (such as data exclusivity) preventing or hindering competitors from entering the market in the respective country, including, but not limited to, exclusivity resulting from Orphan Drug status.
Patent Royalty Term. Section 6.2(a) “Pharmacovigilance Agreement” –Section 4.8 * * * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Patent Royalty Term means, with respect to a given Licensed Product in a given country of Sale, the period, during the Term, prior to the date of expiry of the last to expire Valid Claim Covering such Licensed Product in such country of Sale.
Patent Royalty Term means the period beginning on the First Commercial Sale of a Product in the Territory and ending, on a country by country basis, upon the later of (i) fifteen (15) years following the Effective Date or (ii) the latest date on which such a Product is covered by a Valid Claim in each country in the Territory.
Patent Royalty Term means, on a country-by country basis, the period beginning upon the date of First Commercial Sale of a CD 47 Product (if appropriate) respectively in the applicable country and ending upon the last to occur of: (a) expiration of the last Valid Patent Claim covering the CD 47 Product in the applicable country; or (b) expiration of exclusivity based on regulatory protection (such as data exclusivity) preventing competitors from entering the market in the respective country.